electroCore, Inc. - Common Stock (ECOR)
Healthcare › Electromedical & Electrotherapeutic Apparatus
Price History
Feb 9, 2026 — Mar 27, 2026Investment Snapshot
- P/B of 4.72 — trading above book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -102.2%
- Revenue growing at 27% annually
electroCore, Inc. - Common Stock (ECOR) is a Healthcare company operating in Electromedical & Electrotherapeutic Apparatus, listed on the NASDAQ , with a market capitalisation of $49 million . Key value metrics: P/B ratio 4.72, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
electroCore, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, ECOR shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -102.2% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.05.
StockPik's composite Value Score for ECOR is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ECOR reports a high gross margin of 85.6% (sector average: 33.5%) and a negative operating margin of -43.8%.
ECOR shows revenue growing at 27% year-over-year, with earnings declining at 17%.